{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:54:29Z","timestamp":1793332469484,"version":"4.5.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T00:00:00Z","timestamp":1573516800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Res"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1038\/s41390-019-0663-6","type":"journal-article","created":{"date-parts":[[2019,11,12]],"date-time":"2019-11-12T16:03:06Z","timestamp":1573574586000},"page":"940-945","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Surfactant and budesonide for respiratory distress syndrome: an observational study"],"prefix":"10.1038","volume":"87","author":[{"given":"T. Brett","family":"Kothe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farouk H.","family":"Sadiq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Burleyson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard L.","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noah H.","family":"Hillman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,11,12]]},"reference":[{"key":"663_CR1","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1164\/rccm.201101-0055OC","volume":"183","author":"MM Laughon","year":"2011","unstructured":"Laughon, M. M. et al. Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants. Am. J. Respir. Crit. Care Med. 183, 1715\u20131722 (2011).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"663_CR2","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1542\/peds.2008-0526","volume":"123","author":"N Ambalavanan","year":"2009","unstructured":"Ambalavanan, N. et al. Cytokines associated with bronchopulmonary dysplasia or death in extremely low birth weight infants. Pediatrics 123, 1132\u20131141 (2009).","journal-title":"Pediatrics"},{"key":"663_CR3","doi-asserted-by":"publisher","first-page":"1827","DOI":"10.1016\/S0140-6736(16)00202-6","volume":"387","author":"O Baud","year":"2016","unstructured":"Baud, O. et al. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet 387, 1827\u20131836 (2016).","journal-title":"Lancet"},{"key":"663_CR4","first-page":"CD001146","volume":"10","author":"LW Doyle","year":"2017","unstructured":"Doyle, L. W., Cheong, J. L., Ehrenkranz, R. A. & Halliday, H. L. Early (<8 days) systemic postnatal corticosteroids for prevention of bronchopulmonary dysplasia in preterm infants. Cochrane Database Syst. Rev. 10, CD001146 (2017).","journal-title":"Cochrane Database Syst. Rev."},{"key":"663_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1056\/NEJMoa1708831","volume":"378","author":"D Bassler","year":"2018","unstructured":"Bassler, D. et al. Long-term effects of inhaled budesonide for bronchopulmonary dysplasia. N. Engl. J. Med. 378, 148\u2013157 (2018).","journal-title":"N. Engl. J. Med."},{"key":"663_CR6","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.pedneo.2014.04.009","volume":"56","author":"LT Huang","year":"2015","unstructured":"Huang, L. T., Yeh, T. F., Kuo, Y. L., Chen, P. C. & Chen, C. M. Effect of surfactant and budesonide on the pulmonary distribution of fluorescent dye in mice. Pediatrics Neonatol. 56, 19\u201324 (2015).","journal-title":"Pediatrics Neonatol."},{"key":"663_CR7","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1164\/rccm.201505-0861OC","volume":"193","author":"TF Yeh","year":"2016","unstructured":"Yeh, T. F. et al. Intratracheal administration of budesonide\/surfactant to prevent bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 193, 86\u201395 (2016).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"663_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1365-2125.2008.03164.x","volume":"66","author":"KI van den Brink","year":"2008","unstructured":"van den Brink, K. I. et al. Evidence of the in vivo esterification of budesonide in human airways. Br. J. Clin. Pharmacol. 66, 27\u201335 (2008).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"Suppl C","key":"663_CR9","doi-asserted-by":"publisher","first-page":"C28","DOI":"10.1016\/S0149-2918(03)80304-1","volume":"25","author":"R Brattsand","year":"2003","unstructured":"Brattsand, R. & Miller-Larsson, A. The role of intracellular esterification in budesonide once-daily dosing and airway selectivity. Clin. Therapeut. 25(Suppl C), C28\u2013C41 (2003).","journal-title":"Clin. Therapeut."},{"key":"663_CR10","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1056\/NEJMoa1501917","volume":"373","author":"D Bassler","year":"2015","unstructured":"Bassler, D. et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N. Engl. J. Med. 373, 1497\u20131506 (2015).","journal-title":"N. Engl. J. Med."},{"key":"663_CR11","doi-asserted-by":"crossref","unstructured":"Shinwell, E. S., Portnov, I., Meerpohl, J. J., Karen, T. & Bassler, D. Inhaled corticosteroids for bronchopulmonary dysplasia: a meta-analysis. Pediatrics 138 e20162511 (2016).","DOI":"10.1542\/peds.2016-2511"},{"key":"663_CR12","doi-asserted-by":"publisher","first-page":"e1310","DOI":"10.1542\/peds.2007-1973","volume":"121","author":"TF Yeh","year":"2008","unstructured":"Yeh, T. F. et al. Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics 121, e1310\u2013e1318 (2008).","journal-title":"Pediatrics"},{"key":"663_CR13","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1002\/ppul.23680","volume":"52","author":"R Venkataraman","year":"2017","unstructured":"Venkataraman, R., Kamaluddeen, M., Hasan, S. U., Robertson, H. L. & Lodha, A. Intratracheal administration of budesonide-surfactant in prevention of bronchopulmonary dysplasia in very low birth weight infants: a systematic review and meta-analysis. Pediatr. Pulmonol. 52, 968\u2013975 (2017).","journal-title":"Pediatr. Pulmonol."},{"key":"663_CR14","doi-asserted-by":"publisher","first-page":"1056","DOI":"10.1038\/pr.2017.171","volume":"82","author":"F Ricci","year":"2017","unstructured":"Ricci, F. et al. In vitro and in vivo characterization of poractant alfa supplemented with budesonide for safe and effective intratracheal administration. Pediatr. Res. 82, 1056\u20131063 (2017).","journal-title":"Pediatr. Res."},{"key":"663_CR15","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1002\/ppul.23889","volume":"53","author":"L Li","year":"2018","unstructured":"Li, L. et al. Effects of intratracheal budesonide during early postnatal life on lung maturity of premature fetal rabbits. Pediatr. Pulmonol. 53, 28\u201335 (2018).","journal-title":"Pediatr. Pulmonol."},{"key":"663_CR16","doi-asserted-by":"publisher","first-page":"L193","DOI":"10.1152\/ajplung.00528.2017","volume":"315","author":"TB Kothe","year":"2018","unstructured":"Kothe, T. B. et al. Effects of budesonide and surfactant in preterm fetal sheep. Am. J. Physiol. Lung Cell Mol. Physiol. 315, L193\u2013L201 (2018).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"663_CR17","doi-asserted-by":"publisher","first-page":"L888","DOI":"10.1152\/ajplung.00477.2018","volume":"316","author":"TB Kothe","year":"2019","unstructured":"Kothe, T. B. et al. Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep. Am. J. Physiol. Lung Cell Mol. Physiol. 316, L888\u2013L893 (2019).","journal-title":"Am. J. Physiol. Lung Cell Mol. Physiol."},{"key":"663_CR18","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1165\/rcmb.2016-0068OC","volume":"55","author":"AM Barrette","year":"2016","unstructured":"Barrette, A. M. et al. Antiinflammatory effects of budesonide in human fetal Lung. Am. J. Respir. Cell Mol. Biol. 55, 623\u2013632 (2016).","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"663_CR19","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1124\/dmd.112.046318","volume":"41","author":"CD Moore","year":"2013","unstructured":"Moore, C. D. et al. Metabolic pathways of inhaled glucocorticoids by the CYP3A enzymes. Drug Metab. Dispos. Biol. Fate Chem. 41, 379\u2013389 (2013).","journal-title":"Drug Metab. Dispos. Biol. Fate Chem."},{"issue":"Suppl C","key":"663_CR20","doi-asserted-by":"publisher","first-page":"C42","DOI":"10.1016\/S0149-2918(03)80305-3","volume":"25","author":"EJ O\u2019Connell","year":"2003","unstructured":"O\u2019Connell, E. J. Review of the unique properties of budesonide. Clin. Therapeut. 25(Suppl C), C42\u2013C60 (2003).","journal-title":"Clin. Therapeut."},{"key":"663_CR21","doi-asserted-by":"publisher","first-page":"53","DOI":"10.2174\/1574884710666150929100210","volume":"11","author":"JK Roberts","year":"2016","unstructured":"Roberts, J. K. et al. Pharmacokinetics of budesonide administered with surfactant in premature lambs: implications for neonatal clinical trials. Curr. Clin. Pharm. 11, 53\u201361 (2016).","journal-title":"Curr. Clin. Pharm."},{"key":"663_CR22","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1159\/000493156","volume":"115","author":"CC Claassen","year":"2019","unstructured":"Claassen, C. C., Hillman, N. H., Brown, K., Williams, H. L. & Strand, M. L. Comparison of bubble CPAP devices using RAM cannula for extubation failure in very low birth weight infants: randomized and cohort studies. Neonatology 115, 28\u201335 (2019).","journal-title":"Neonatology"},{"key":"663_CR23","doi-asserted-by":"publisher","first-page":"1970","DOI":"10.1056\/NEJMoa0911783","volume":"362","author":"NN Finer","year":"2010","unstructured":"Finer, N. N. et al. Early CPAP versus surfactant in extremely preterm infants. N. Engl. J. Med 362, 1970\u20131979 (2010).","journal-title":"N. Engl. J. Med"},{"key":"663_CR24","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1016\/S0140-6736(03)13397-1","volume":"361","author":"G Parry","year":"2003","unstructured":"Parry, G., Tucker, J. & Tarnow-Mordi, W., Group UKNSSC. CRIB II: an update of the clinical risk index for babies score. Lancet 361, 1789\u20131791 (2003).","journal-title":"Lancet"},{"key":"663_CR25","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1542\/peds.2005-0249","volume":"116","author":"RA Ehrenkranz","year":"2005","unstructured":"Ehrenkranz, R. A. et al. Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia. Pediatrics 116, 1353\u20131360 (2005).","journal-title":"Pediatrics"},{"key":"663_CR26","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1164\/ajrccm.163.7.2011060","volume":"163","author":"AH Jobe","year":"2001","unstructured":"Jobe, A. H. & Bancalari, E. Bronchopulmonary dysplasia. Am. J. Respir. Crit. Care Med. 163, 1723\u20131729 (2001).","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"663_CR27","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.jpeds.2016.10.082","volume":"181","author":"SH Abman","year":"2017","unstructured":"Abman, S. H. et al. Interdisciplinary care of children with severe bronchopulmonary dysplasia. J. Pediatr. 181, 12\u201328 e1 (2017).","journal-title":"J. Pediatr."},{"key":"663_CR28","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jpeds.2018.01.043","volume":"197","author":"RD Higgins","year":"2018","unstructured":"Higgins, R. D. et al. Bronchopulmonary dysplasia: executive summary of a workshop. J. Pediatr. 197, 300\u2013308 (2018).","journal-title":"J. Pediatr."},{"key":"663_CR29","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1542\/peds.2004-2843","volume":"117","author":"LW Doyle","year":"2006","unstructured":"Doyle, L. W. et al. Low-dose dexamethasone facilitates extubation among chronically ventilator-dependent infants: a multicenter, international, randomized, controlled trial. Pediatrics 117, 75\u201383 (2006).","journal-title":"Pediatrics"},{"key":"663_CR30","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/apa.14469","volume":"108","author":"SM Juhl","year":"2019","unstructured":"Juhl, S. M., Hansen, M. L., Gormsen, M., Skov, T. & Greisen, G. Staging of necrotising enterocolitis by Bell\u2019s criteria is supported by a statistical pattern analysis of clinical and radiological variables. Acta Paediatr. 108, 842\u2013848 (2019).","journal-title":"Acta Paediatr."},{"key":"663_CR31","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jamaophthalmol.2018.4290","volume":"136","author":"GE Quinn","year":"2018","unstructured":"Quinn, G. E. et al. Incidence and early course of retinopathy of prematurity: secondary analysis of the postnatal growth and retinopathy of prematurity (G-ROP) study. JAMA Ophthalmol. 136, 1383\u20131389 (2018).","journal-title":"JAMA Ophthalmol."},{"key":"663_CR32","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1001\/jama.289.9.1124","volume":"289","author":"B Schmidt","year":"2003","unstructured":"Schmidt, B. et al. Impact of bronchopulmonary dysplasia, brain injury, and severe retinopathy on the outcome of extremely low-birth-weight infants at 18 months: results from the trial of indomethacin prophylaxis in preterms. JAMA 289, 1124\u20131129 (2003).","journal-title":"JAMA"},{"key":"663_CR33","doi-asserted-by":"publisher","first-page":"982","DOI":"10.1016\/j.jpeds.2015.07.067","volume":"167","author":"B Schmidt","year":"2015","unstructured":"Schmidt, B. et al. Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants. J. Pediatr. 167, 982\u2013986 e2 (2015).","journal-title":"J. Pediatr."},{"key":"663_CR34","first-page":"78","volume":"25","author":"L Boel","year":"2018","unstructured":"Boel, L., Banerjee, S. & Chakraborty, M. Postnatal steroids in extreme preterm infants: Intra-tracheal instillation using surfactant as a vehicle. Paediatr. Respir. Rev. 25, 78\u201384 (2018).","journal-title":"Paediatr. Respir. Rev."},{"key":"663_CR35","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1056\/NEJMoa1501917","volume":"373","author":"D Bassler","year":"2015","unstructured":"Bassler, D. et al. Early inhaled budesonide for the prevention of bronchopulmonary dysplasia. N. Engl. J. Med. 373, 1497\u20131506 (2015).","journal-title":"N. Engl. J. Med."},{"key":"663_CR36","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1016\/S0928-0987(97)00082-1","volume":"6","author":"N Esmailpour","year":"1998","unstructured":"Esmailpour, N., Hogger, P. & Rohdewald, P. Binding kinetics of budesonide to the human glucocorticoid receptor. Eur. J. Pharm. Sci. 6, 219\u2013223 (1998).","journal-title":"Eur. J. Pharm. Sci."},{"key":"663_CR37","first-page":"L888","volume":"316","author":"TBRE Kothe","year":"2019","unstructured":"Kothe, T. B. R. E. et al. Surfactant plus budesonide decreases lung and systemic inflammation in mechanically ventilated preterm sheep. AJP-Lung 316, L888\u2013L893 (2019).","journal-title":"AJP-Lung"},{"key":"663_CR38","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1067\/mpd.2002.121381","volume":"140","author":"LJ Van Marter","year":"2002","unstructured":"Van Marter, L. J. et al. Chorioamnionitis, mechanical ventilation, and postnatal sepsis as modulators of chronic lung disease in preterm infants. J. Pediatr. 140, 171\u2013176 (2002).","journal-title":"J. Pediatr."}],"container-title":["Pediatric Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0663-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0663-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41390-019-0663-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T21:28:45Z","timestamp":1684618125000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41390-019-0663-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11,12]]},"references-count":38,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["663"],"URL":"https:\/\/doi.org\/10.1038\/s41390-019-0663-6","relation":{},"ISSN":["0031-3998","1530-0447"],"issn-type":[{"value":"0031-3998","type":"print"},{"value":"1530-0447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,11,12]]},"assertion":[{"value":"13 March 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 September 2019","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 October 2019","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2019","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}